Onconetix, Inc. Accounts Payable and Accrued Liabilities
Onconetix, Inc. (ONCO) had Accounts Payable and Accrued Liabilities of $900.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-17.
Discontinued › Balance Sheet › Liabilities
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent · last filed 2024-04-11
- 2023-09-30: Accounts Payable and Accrued Liabilities $900.00K.
- 2022-12-31: Accounts Payable and Accrued Liabilities $669.00K.
| Period end | Accounts Payable and Accrued Liabilities |
|---|---|
| 2023-09-30 | $900.00K 10-Q · filed 2023-11-17 |
| 2022-12-31 | $669.00K 10-K · filed 2024-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |